Hostname: page-component-8448b6f56d-cfpbc Total loading time: 0 Render date: 2024-04-19T22:34:35.867Z Has data issue: false hasContentIssue false
  • English
  • Français

Reproductive Health and Bipolar Disorder

Published online by Cambridge University Press:  07 November 2014

Trisha Suppes
Trisha Suppes*
Affiliation:
Dr. Suppes is professor of psychiatry in the Department of Psychiatry at the, University of Texas Southwestern Medical Centerin Dallas.
Get access Rights & Permissions [Opens in a new window]

Abstract

The presentations and clinical courses of patients with bipolar disorder differ greatly by gender. In addition, medical therapy must be tailored differently for men and women because of emerging safety concerns unique to the female reproductive system. In November 2005, these topics were explored by a panel of experts in psychiatry, neurology, and reproductive health at a closed roundtable meeting in Dallas, Texas. This clinical information monograph summarizes the highlights of that meeting.

Compared to men with bipolar disorder, women have more pervasive depressive symptoms and experience more major depressive episodes. They are also at higher risk for obesity and certain other medical and psychiatric comorbidities. Mood changes across the menstrual cycle are common, although the severity, timing, and type of changes are variable. Bipolar disorder is frequently associated with menstrual abnormalities and ovarian dysfunction, including polycystic ovarian syndrome. Although some cases of menstrual disturbance precede the treatment of bipolar disorder, it is possible that valproate and/or antipsychotic treatment may play a contributory role in young women.

Pregnancy does not protect against mood episodes in untreated women. Maintenance of euthymia during pregnancy is critical because relapse during this period strongly predicts a difficult postpartum course. Suspending therapy in the first months of pregnancy may be an option for some women with mild-to-moderate illness, or those with a long history of euthymia during pre-pregnancy treatment. However, a mood stabilizer should be reintroduced either in the later stages of pregnancy or in the immediate postpartum period. Preliminary data suggest that fetal exposure to some mood stabilizers may raise the risk of major congenital malformations and neurodevelopmental delays. For women planning to become pregnant, clinicians may consider switching to other drugs before conception. The value and drawbacks of breastfeeding during treatment must be considered in partnership with the patient, with close monitoring of nursing infants thereafter. The risks and benefits of medical treatment for women with bipolar disorder should be carefully reconsidered at each stage of their reproductive lives, with a flexible approach that is responsive to the changing needs of patients and their families.

Type
Research Article
Information
CNS Spectrums , Volume 11 , Issue S5 , May 2006 , pp. 1 - 16
Copyright
Copyright © Cambridge University Press 2003

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Angst, J. The course of affective disorders. II. Typology of bipolar manic-depressive illness. Arch Psychiatr Nervenkr. 1978;226:65–73.CrossRefGoogle ScholarPubMed
2.Leibenluft, E. Women with bipolar illness: clinical and research issues. Am J Psychiatry. 1996;153:163–173.Google ScholarPubMed
3.Freeman, MP, McElroy, SL. Clinical picture and etiologic models of mixed states. Psychiatr Clin North Am. 1999;22:535–546.CrossRefGoogle ScholarPubMed
4.Judd, KL, Akiskal, HS, Schettler, PJ, et al.The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry. 2002;59:530–537.CrossRefGoogle ScholarPubMed
5.Post, RM, Leverich, GS, Altshuler, LL, et al.An overview of recent findings of the Stanley Foundation Bipolar Network (Part I). Bipolar Disord. 2003;5:310–319.CrossRefGoogle ScholarPubMed
6.Hendrick, V, Altshuler, LL, Gitlin, MJ, Delrahim, S, Hammen, C. Gender and bipolar illness. J Clin Psychiatry. 2000;61:393–396.CrossRefGoogle ScholarPubMed
7.Tondo, L, Baldessarini, RJ. Rapid cycling in women and men with bipolar manic-depressive disorders. Am J Psychiatry. 1998;155:1434–1436.CrossRefGoogle ScholarPubMed
8.Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.Google Scholar
9.Suppes, T, Leverich, GS, Keck, PE, et al.The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. J Affect Disord. 2001;67:45–59.CrossRefGoogle ScholarPubMed
10.Kawa, I, Carter, JD, Joyce, PR, et al.Gender differences in bipolar disorder: age of onset, course, comorbidity, and symptom presentation. Bipolar Disord. 2005;7:119–125.CrossRefGoogle ScholarPubMed
11.Benazzi, F. Gender differences in bipolar II and unipolar depressed outpatients: a 557-case study. Ann Clin Psychiatry. 1999;11:55–59.CrossRefGoogle ScholarPubMed
12.Rasgon, NL, et al. Presented at: 153rd Annual Meeting of the American Psychiatric Association; May 13-20, 2000; Chicago, Ill.Google Scholar
13.Leverich, GS, McElroy, SL, Suppes, T, et al.Early physical and sexual abuse associated with an adverse course of bipolar illness. Biol Psychiatry. 2002;51(4):288–297.CrossRefGoogle ScholarPubMed
14.Suppes, T, Mintz, J, McElroy, SL, et al.Mixed hypomania in 908 patients with bipolar disorder evaluated prospectively in the Stanley Foundation Bipolar Treatment Network: a sex-specific phenomenon. Arch Gen Psychiatry. 2005;62(10):1089–1096.CrossRefGoogle ScholarPubMed
15.McElroy, SL, Frye, MA, Suppes, T, et al.Correlates of overweight and obesity in 644 patients with bipolar disorder. J Clin Psychiatry. 2002;63:207–213.CrossRefGoogle ScholarPubMed
16.Ford, ES, Giles, WH, Dietz, WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356–359.CrossRefGoogle ScholarPubMed
17.Park, YW, Zhu, S, Palaniappan, L, Heshka, S, Carnethon, MR, Heymsfield, SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2003;163:427–423.CrossRefGoogle ScholarPubMed
18.Krishnan, KR. Psychiatric and medical comorbidities of bipolar disorder. Psychosom Med. 2005;67(1):1–8.CrossRefGoogle ScholarPubMed
19.Baldassano, CF, Marangell, LB, Gyulai, L, et al.Gender differences in bipolar disorder: retrospective data from the first 500 STEP-BD participants. Bipolar Disord. 2005;7(5):465–470.CrossRefGoogle ScholarPubMed
20.Helzer, JE, Burnan, A, McEvoy, LT. Alcohol abuse and dependence. In: Psychiatric Disorders in America: The Epidemiologic Catchment Area Study. Robins, LN, Regier, DA, eds. New York, NY: Free Press: 1991;81–115.Google Scholar
21.Frye, MA, Altshuler, LL, McElroy, SL, et al.Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder. Am J Psychiatry. 2003;160:883–889.CrossRefGoogle ScholarPubMed